Cognitive impairments in HCV infection: From pathogenesis to neuroimaging

References

• Abrantes, J., Torres, D. S., & de Mello, C. E. B. (2013). Patients with hepatitis C infection and normal liver function: an evaluation of cognitive function. Postgraduate Medical Journal, 89(1054), 433–439.
   PubMed Web of Science ®Google Scholar
• Abu Faddan, N., Shehata, G., Abd Elhafeez, H., Mohamed, A., Hassan, H., & Abd El Sameea, F. (2015). Cognitive function and endogenous cytokine levels in children with chronic hepatitis C. Journal of Viral Hepatitis, 22(8), 665–670.
   PubMed Web of Science ®Google Scholar
• Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., … Kwo, P. (2014). Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. New England Journal of Medicine, 370(16), 1483–1493.
   PubMed Web of Science ®Google Scholar
• Ambrosino, P., Lupoli, R., Di Minno, A., Tarantino, L., Spadarella, G., Tarantino, P., … Di Minno, M. N. D. (2016). The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis. International Journal of Cardiology, 221, 746–754.
   PubMed Web of Science ®Google Scholar
• Amodio, P., De Toni, E. N., Cavalletto, L., Mapelli, D., Bernardinello, E., Del Piccolo, F., … Perini, G. (2005). Mood, cognition and EEG changes during interferon α (alpha-IFN) treatment for chronic hepatitis C. Journal of Affective Disorders, 84(1), 93–98.
   PubMed Web of Science ®Google Scholar
• Aregay, A., Dirks, M., Schlaphoff, V., Owusu Sekyere, S., Haag, K., Falk, C. S., … Weissenborn, K. (2018). Systemic inflammation and immune cell phenotypes are associated with neuro‐psychiatric symptoms in patients with chronic inflammatory liver diseases. Liver International.
   PubMed Web of Science ®Google Scholar
• Barbosa, M. E. D., Zaninotto, A. L., de Campos Mazo, D. F., Pessoa, M. G., CPMS, D. O., Carrilho, F. J., & Farias, A. Q. (2017). Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin. BMC Gastroenterology, 17(1), 122.
   PubMed Web of Science ®Google Scholar
• Bassendine, M. F., Nielsen, S. U., Bridge, S. H., Felmlee, D. J., Sheridan, D. A., Packard, C. J., & Neely, R. D. (2017). Hepatitis C virus and atherosclerosis: A legacy after virologic cure? Clinics and Research in Hepatology and Gastroenterology, 41(1), 25–30.
   PubMed Web of Science ®Google Scholar
• Bieliauskas, L. A., Back-Madruga, C., Lindsay, K. L., Wright, E. C., Kronfol, Z., Lok, A. S., & Fontana, R. J. (2007). Cognitive reserve and neuropsychological functioning in patients infected with hepatitis C. Journal of the International Neuropsychological Society, 13(4), 687–692.
   PubMed Web of Science ®Google Scholar
• Bladowska, J., Knysz, B., Zimny, A., Małyszczak, K., Kołtowska, A., Szewczyk, P., … Chao, L. (2014). Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients. PloS One, 9(7), e102214.
   PubMed Web of Science ®Google Scholar
• Bladowska, J., Pawłowski, T., Fleischer‐Stępniewska, K., Knysz, B., Małyszczak, K., Żelwetro, A., … Sąsiadek, M. (2019). Interferon‐free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C. Journal of Viral Hepatitis, 26, 635–643.
   PubMed Web of Science ®Google Scholar
• Bladowska, J., Zimny, A., Knysz, B., Małyszczak, K., Kołtowska, A., Szewczyk, P., … Sąsiadek, M. J. (2013). Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study. Journal of Hepatology, 59(4), 651–657.
   PubMed Web of Science ®Google Scholar
• Bokemeyer, M., Ding, X., Goldbecker, A., Raab, P., Heeren, M., Arvanitis, D., Tillmann, H. L., Lanfermann, H., Weissenborn, K., (2010). Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut, 2010, 217976.
   Google Scholar
• Bourliere, M., Oules, V., Ansaldi, C., Adhoute, X., & Castellani, P. (2014). Sofosbuvir as backbone of interferon free treatments. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 46(Suppl 5), S212–S220.
   PubMedGoogle Scholar
• Bychenko, A., Samokhvalov, E., Markova, N., Rusanova, O., Rzhaninova, A., Tentsov, Y. Y., … Sukhikh, G. T. (2000). In vivo and in vitro modelling of hepatitis C virus infection. Bulletin of Experimental Biology and Medicine, 129(3), 267–270.
   Web of Science ®Google Scholar
• Byrnes, V., Miller, A., Lowry, D., Hill, E., Weinstein, C., Alsop, D., … Afdhal, N. H. (2012). Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. Journal of Hepatology, 56(3), 549–556.
   PubMed Web of Science ®Google Scholar
• Cacoub, P., Renou, C., Rosenthal, E., Cohen, P., Loury, I., Loustaud-Ratti, V., … Piette, J. C. (2000). Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine, 79(1), 47–56.
   PubMed Web of Science ®Google Scholar
• Campagna, F., Montagnese, S., Schiff, S., Ruzzoli, M., Biancardi, A., Iannizzi, P., … Amodio, P. (2015). Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study. Liver International, 35(5), 1524–1532.
   PubMed Web of Science ®Google Scholar
• Castro Caldas, A., Geraldes, R., Neto, L., Canhao, P., & Melo, T. P. (2014). Central nervous system vasculitis associated with hepatitis C virus infection: a brain MRI-supported diagnosis. Journal of the Neurological Sciences, 336(1–2), 152–154.
   PubMed Web of Science ®Google Scholar
• Cattie, J. E., Letendre, S. L., Woods, S. P., Barakat, F., Perry, W., Cherner, M., … Grant, I. (2014). Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. Journal of Neurovirology, 20(6), 561–570.
   PubMed Web of Science ®Google Scholar
• Córdoba, J., Flavià, M., Jacas, C., Sauleda, S., Esteban, J. I., Vargas, V., … Guardia, J. (2003). Quality of life and cognitive function in hepatitis C at different stages of liver disease. Journal of Hepatology, 39(2), 231–238.
   PubMed Web of Science ®Google Scholar
• Dipasquale, O., Cooper, E. A., Tibble, J., Voon, V., Baglio, F., Baselli, G., … Harrison, N. A. (2016). Interferon-alpha acutely impairs whole-brain functional connectivity network architecture - A preliminary study. Brain, Behavior, and Immunity, 58, 31–39.
   PubMed Web of Science ®Google Scholar
• Ducoulombier, D., Roque‐Afonso, A. M., Di Liberto, G., Penin, F., Kara, R., Richard, Y., … Féray, C. (2004). Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology, 39(3), 817–825.
   PubMed Web of Science ®Google Scholar
• Feld, J. J. (2012). Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection. Best Practice & Research Clinical Gastroenterology, 26(4), 429–444.
   PubMed Web of Science ®Google Scholar
• Feld, J. J., Kowdley, K. V., Coakley, E., Sigal, S., Nelson, D. R., Crawford, D., … Bernstein, B. (2014). Treatment of HCV with ABT-450/r–ombitasvir and dasabuvir with ribavirin. The New England Journal of Medicine, 370(17), 1594–1603.
   PubMed Web of Science ®Google Scholar
• Fialho, R., Pereira, M., Gilleece, Y., Rusted, J., & Whale, R. (2019). A longitudinal study assessing depression in hepatitis C: Does gender play a role in the new-onset depression during interferon-alpha treatment? Women & Health, 59(2), 181–195.
   PubMed Web of Science ®Google Scholar
• Fletcher, N. F., Wilson, G. K., Murray, J., Hu, K., Lewis, A., Reynolds, G. M., … McKeating, J. A. (2012). Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology, 142(3), 634–43. e6.
   PubMed Web of Science ®Google Scholar
• Fontana, R. (2000). Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C. Digestive Diseases, 18(3), 107–116.
   PubMed Web of Science ®Google Scholar
• Fontana, R. J., Bieliauskas, L. A., Back-Madruga, C., Lindsay, K. L., Litman, H. J., Lok, A. S., & Kronfol, Z. (2010). Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis C. The American Journal of Gastroenterology, 105(7), 1551.
   PubMed Web of Science ®Google Scholar
• Fontana, R. J., Bieliauskas, L. A., Lindsay, K. L., Back‐Madruga, C., Wright, E. C., Snow, K. K., … Padmanabhan, L. (2007). Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology, 45(5), 1154–1163.
   PubMed Web of Science ®Google Scholar
• Forton, D. M., Allsop, J. M., Cox, I. J., Hamilton, G., Wesnes, K., Thomas, H. C., & Taylor-Robinson, S. D. (2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. Aids, 19, S53–S63.
   PubMed Web of Science ®Google Scholar
• Forton, D. M., Hamilton, G., Allsop, J. M., Grover, V. P., Wesnes, K., O’Sullivan, C., … Taylor-Robinson, S. D. (2008). Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study. Journal of Hepatology, 49(3), 316–322.
   PubMed Web of Science ®Google Scholar
• Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., … Taylor-Robinson, S. D. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35(2), 433–439.
   PubMed Web of Science ®Google Scholar
• Foster, G. R., Afdhal, N., Roberts, S. K., Bräu, N., Gane, E. J., Pianko, S., … Sulkowski, M. (2015). Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. The New England Journal of Medicine, 373(27), 2608–2617.
   PubMed Web of Science ®Google Scholar
• Gochee, P. A., Powell, E. E., Purdie, D. M., Pandeya, N., Kelemen, L., Shorthouse, C., … Kelly, B. (2004). Association between apolipoprotein E ɛ4 and neuropsychiatric symptoms during interferon α treatment for chronic hepatitis C. Psychosomatics, 45(1), 49–57.
   PubMed Web of Science ®Google Scholar
• Gould, T. J. (2010). Addiction and Cognition. Addiction Science & Clinical Practice, 5(2), 4–14.
   PubMedGoogle Scholar
• Grover, V., Pavese, N., Koh, S. B., Wylezinska, M., Saxby, B., Gerhard, A., … Taylor-Robinson, S. D. (2012). Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. Journal of Viral Hepatitis, 19(2), e89-96.
   PubMed Web of Science ®Google Scholar
• Haroon, E., Woolwine, B. J., Chen, X., Pace, T. W., Parekh, S., Spivey, J. R., … Miller, A. H. (2014). IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 39(7), 1777–1785.
   PubMed Web of Science ®Google Scholar
• He, H. (2013). Hepatitis C virus infection and risk of stroke: A systematic review and meta-analysis.  PLoS ONE 8(11), e81305.
   Google Scholar
• Heaps-Woodruff, J. M., Wright, P. W., Ances, B. M., Clifford, D., & Paul, R. H. (2016). The impact of human immune deficiency virus and hepatitis C coinfection on white matter microstructural integrity. Journal of Neurovirology, 22(3), 389–399.
   PubMed Web of Science ®Google Scholar
• Heeren, M., Weissenborn, K., Arvanitis, D., Bokemeyer, M., Goldbecker, A., Tountopoulou, A., … Berding, G. (2011). Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. Journal of Cerebral Blood Flow & Metabolism, 31(11), 2199–2208.
   PubMed Web of Science ®Google Scholar
• Hilsabeck, R. C., Hassanein, T. I., Carlson, M. D., Ziegler, E. A., & Perry, W. (2003). Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. Journal of the International Neuropsychological Society, 9(6), 847–854.
   PubMed Web of Science ®Google Scholar
• Hilsabeck, R. C., Perry, W., & Hassanein, T. I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35(2), 440–446.
   PubMed Web of Science ®Google Scholar
• Hjerrild, S., Renvillard, S. G., Leutscher, P., Sørensen, L. H., Østergaard, L., Eskildsen, S. F., & Videbech, P. (2016). Reduced cerebral cortical thickness in Non-cirrhotic patients with hepatitis C. Metabolic Brain Disease, 31(2), 311–319.
   PubMed Web of Science ®Google Scholar
• Huckans, M., Fuller, B., Wheaton, V., Jaehnert, S., Ellis, C., Kolessar, M., … Loftis, J. M. (2015). A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. Journal of Psychosomatic Research, 78(2), 184–192.
   PubMed Web of Science ®Google Scholar
• Huckans, M., Seelye, A., Parcel, T., Mull, L., Woodhouse, J., Bjornson, D., … Hauser, P. (2009). The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. Journal of the International Neuropsychological Society, 15(1), 69–82.
   PubMed Web of Science ®Google Scholar
• Huckans, M., Seelye, A., Woodhouse, J., Parcel, T., Mull, L., Schwartz, D., … Hoffman, W. (2011). Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. Journal of Clinical and Experimental Neuropsychology, 33(2), 176–186.
   PubMed Web of Science ®Google Scholar
• Hussein, N. R. (2017). The efficacy and safety of sofosbuvir-containing regimen in the treatment of HCV infection in patients with haemoglobinopathy. Mediterranean Journal of Hematology and Infectious Diseases, 9(1), e2017005.
   PubMed Web of Science ®Google Scholar
• Hussein, N. R., Saleema, Z. S., & Abd, Q. H. (2019). Direct acting antiviral treatment for patients with end-stage kidney disease with acute HCV infection. Mediterranean Journal of Hematology and Infectious Diseases, 11(1), e2019034.
   PubMed Web of Science ®Google Scholar
• Ibrahim, I., Salah, H., El Sayed, H., Mansour, H., Eissa, A., Wood, J., … Nimgaonkar, V. (2016). Hepatitis C virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample. Journal of Clinical and Experimental Neuropsychology, 38(8), 861–868.
   PubMed Web of Science ®Google Scholar
• Irwin, J., & Terrault, N. (2008). Cognitive impairment in hepatitis C patients on antiviral therapy. Gastroenterology & Hepatology, 4(1), 65.
   Google Scholar
• Iwasa, M., Mifuji-Moroka, R., Kuroda, M., Moroka, H., Fujita, N., Kobayashi, Y., … Takei, Y. (2012). Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRI. Metabolic Brain Disease, 27(4), 551–557.
   PubMed Web of Science ®Google Scholar
• Karaivazoglou, K., Assimakopoulos, K., Thomopoulos, K., Theocharis, G., Messinis, L., Sakellaropoulos, G., & Labropoulou-Karatza, C. (2007). Neuropsychological function in Greek patients with chronic hepatitis C. Liver International, 27(6), 798–805.
   PubMed Web of Science ®Google Scholar
• Kharabian Masouleh, S., Herzig, S., Klose, L., Roggenhofer, E., Tenckhoff, H., Kaiser, T., … Villringer, A. (2017). Functional connectivity alterations in patients with chronic hepatitis C virus infection: A multimodal MRI study. Journal of Viral Hepatitis, 24(3), 216–225.
   PubMed Web of Science ®Google Scholar
• Kleefeld, F., Heller, S., Ingiliz, P., Jessen, H., Petersen, A., Kopp, U., Kraft, A., Hahn, K. (2018). Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health. Journal of Neurovirology, 24(5), 557–569.
   PubMed Web of Science ®Google Scholar
• Kleefeld, F., Heller, S., Jessen, H., Ingiliz, P., Kraft, A., & Hahn, K. (2017). Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: a pilot study. Neurology, 88(7), 713–715.
   PubMed Web of Science ®Google Scholar
• Kramer, L., Bauer, E., Funk, G., Hofer, H., Jessner, W., Steindl-Munda, P., … Ferenci, P. (2002). Subclinical impairment of brain function in chronic hepatitis C infection. Journal of Hepatology, 37(3), 349–354.
   PubMed Web of Science ®Google Scholar
• Kraus, M. R., Schäfer, A., Teuber, G., Porst, H., Sprinzl, K., Wollschläger, S., … Scheurlen, M. (2013). Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C. Hepatology, 58(2), 497–504.
   PubMed Web of Science ®Google Scholar
• Kraus, M. R., Schäfer, A., Wißmann, S., Reimer, P., & Scheurlen, M. (2005). Neurocognitive changes in patients with hepatitis C receiving interferon alfa‐2b and ribavirin. Clinical Pharmacology & Therapeutics, 77(1), 90–100.
   PubMed Web of Science ®Google Scholar
• Kuhn, T., Sayegh, P., Jones, J. D., Smith, J., Sarma, M. K., Ragin, A., … Hinkin, C. H. (2017). Improvements in brain and behavior following eradication of hepatitis C. Journal of Neurovirology, 23(4), 593–602.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Deep, A., Gupta, R. K., Atam, V., & Mohindra, S. (2017). Brain microstructural correlates of cognitive dysfunction in clinically and biochemically normal hepatitis C virus infection. Journal of Clinical and Experimental Hepatology, 7(3), 198–204.
   PubMed Web of Science ®Google Scholar
• Laskus, T., Radkowski, M., Adair, D. M., Wilkinson, J., Scheck, A. C., & Rakela, J. (2005). Emerging evidence of hepatitis C virus neuroinvasion. Aids, 19, S140–S144.
   PubMed Web of Science ®Google Scholar
• Lee, M.-H., Yang, H.-I., Wang, C.-H., Jen, C.-L., Yeh, S.-H., Liu, C.-J., … Chen, C.-J. (2010). Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke, 41(12), 2894–2900.
   PubMed Web of Science ®Google Scholar
• Lerat, H., Rumin, S., Habersetzer, F., Berby, F., Trabaud, M.-A., Trépo, C., & Inchauspé, G. (1998). In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood, 91(10), 3841–3849.
   PubMed Web of Science ®Google Scholar
• Letendre, S., Paulino, A. D., Rockenstein, E., Adame, A., Crews, L., Cherner, M., … Masliah, E. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. The Journal of Infectious Diseases, 196(3), 361–370.
   PubMed Web of Science ®Google Scholar
• Lidar, M., Lipschitz, N., Agmon-Levin, N., Langevitz, P., Barzilai, O., Ram, M., … Shoenfeld, Y. (2012). Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia. Clinical Reviews in Allergy & Immunology, 42(2), 238–246.
   PubMed Web of Science ®Google Scholar
• Liu, Z., Zhao, F., & He, J. J. (2014). Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18. Journal of Neurovirology, 20(3), 278–293.
   PubMed Web of Science ®Google Scholar
• Maggi, F., Giorgi, M., Fornai, C., Morrica, A., Vatteroni, M. L., Pistello, M., … Bendinelli, M. (1999). Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. Journal of Neurovirology, 5(3), 319–323.
   PubMed Web of Science ®Google Scholar
• Majer, M., Welberg, L. A., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008). IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain, Behavior, and Immunity, 22(6), 870–880.
   PubMed Web of Science ®Google Scholar
• Mapoure, N., Budzi, M., Eloumou, S., Malongue, A., Okalla, C., & Luma, H. (2018). Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PloS One, 13(3), e0192406.
   PubMed Web of Science ®Google Scholar
• Marcellin, F., Protopopescu, C., Poizot-Martin, I., Miailhes, P., Esterle, L., Wittkop, L., … Carrieri, M. P. (2016). Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). European Journal of Gastroenterology & Hepatology, 28(9), 1003–1007.
   PubMed Web of Science ®Google Scholar
• Martindale, S. L., Hurley, R. A., & Taber, K. H. (2017). Neurobiology and neuroimaging of chronic hepatitis C Virus: Implications for neuropsychiatry. The Journal of Neuropsychiatry and Clinical Neurosciences, 29(4), A6–A307.
   PubMed Web of Science ®Google Scholar
• Mastrorosa, I., Lorenzini, P., Ricottini, M., Fabbri, G., Balestra, P., Vergori, A., Pinnetti, C., Zaccarelli, M., Ammassari, A., Antinori, A. (2017). DAAs improve VACS but do not influence cognitive impairment in HIV/HCV coinfected. Seattle (WA): CROI.
   Google Scholar
• McAndrews, M. P., Farcnik, K., Carlen, P., Damyanovich, A., Mrkonjic, M., Jones, S., & Heathcote, E. J. (2005). Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology, 41(4), 801–808.
   PubMed Web of Science ®Google Scholar
• Mendoza-Fernandez, V., Andrew, R. D., & Barajas-Lopez, C. (2000). Interferon-α inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Research, 885(1), 14–24.
   PubMed Web of Science ®Google Scholar
• Miao, Z., Xie, Z., Miao, J., Ran, J., Feng, Y., & Xia, X. (2017). Regulated entry of hepatitis C virus into hepatocytes. Viruses, 9(5), 100.
   Web of Science ®Google Scholar
• Micali, E., Squadrito, G., Abbate, C., Raimondo, G., Trimarchi, F., & Barbaro, M. (2007). Cognitive performances in workers with chronic virus hepatitis (HBV-HCV). Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia, 29(3 Suppl), 757–760.
   PubMedGoogle Scholar
• Monaco, S., Mariotto, S., Ferrari, S., Calabrese, M., Zanusso, G., Gajofatto, A., … Duan, J. (2015). Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: advances in 2015. World Journal of Gastroenterology, 21(42), 11974.
   PubMed Web of Science ®Google Scholar
• Monteiro, S., Ferreira, F. M., Pinto, V., Roque, S., Morais, M., de Sá-Calçada, D., … Cerqueira, J. J. (2016). Absence of IFNγ promotes hippocampal plasticity and enhances cognitive performance. Translational Psychiatry, 6(1), e707.
   PubMed Web of Science ®Google Scholar
• Morgan, E. E., Woods, S. P., Rooney, A., Perry, W., Grant, I., Letendre, S. L., HIV Neurobehavioral Research Program HNRP Group. (2012). Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk. The Clinical Neuropsychologist, 26(4), 654–674.
   PubMed Web of Science ®Google Scholar
• Naggie, S., Cooper, C., Saag, M., Workowski, K., Ruane, P., Towner, W. J., … Sulkowski, M. (2015). Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. New England Journal of Medicine, 373(8), 705–713.
   PubMed Web of Science ®Google Scholar
• Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., & Manns, M. P. (2015). Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology, 149(6), 1345–1360.
   PubMed Web of Science ®Google Scholar
• Nitkunan, A., McIntyre, D. J., Barrick, T. R., O’Sullivan, M., Shen, Y., Clark, C. A., Howe, F. A., Markus, H. S. (2006). Correlations between MRS and DTI in cerebral small vessel disease. NMR in Biomedicine, 19(5), 610–616.
   PubMed Web of Science ®Google Scholar
• Origgi, L., Grasso, M., Vanoll, M., Carbone, A., & Scorza, R. (1998). Central nervous system involvement in patients with HCV-related cryoglobulinemia. The American Journal of the Medical Sciences, 315(3), 208–210.
   PubMed Web of Science ®Google Scholar
• Oriolo, G., Egmond, E., Mariño, Z., Cavero, M., Navines, R., Zamarrenho, L., … Martin-Santos, R. (2018). Systematic review with meta-analysis: neuroimaging in hepatitis C chronic infection. Alimentary Pharmacology & Therapeutics, 47(9), 1238–1252.
   PubMed Web of Science ®Google Scholar
• Chung R. T., Ghany M. G., Kim A. Y., Marks K. M., Naggie S., Vargas H. E., … Workowski K. A. (2018). Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology, 67(10), 1477–1492.
   Google Scholar
• Pattullo, V., McAndrews, M. P., Damyanovich, A., & Heathcote, E. J. (2011). Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes. Liver International: Official Journal of the International Association for the Study of the Liver, 31(7), 1028–1038.
   PubMed Web of Science ®Google Scholar
• Pawełczyk, T., Pawełczyk, A., Białkowska, J., Jabłkowski, M., Strzelecki, D., Dworniak, D., & Rabe-Jabłońska, J. (2008). Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy. Psychiatria Polska, 42(6), 925–941.
   PubMed Web of Science ®Google Scholar
• Perry, W., Hilsabeck, R. C., & Hassanein, T. I. (2008). Cognitive dysfunction in chronic hepatitis C: a review. Digestive Diseases and Sciences, 53(2), 307–321.
   PubMed Web of Science ®Google Scholar
• Pes, F., Onali, S., Balestrieri, C., Figorilli, F., Serra, G., Pasetto, C., et al., Evaluation of mild cognitive dysfunction by Montreal cognitive assessment test in co-infected HIV-HCV patients treated with the new direct acting antivirals (DAAs). Italian Conference on AIDS and Antiviral Research 9° Congresso Nazionale Milan; 2017: ITA.
   Google Scholar
• Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A., & Cacciapuoti, C. (2016). Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World Journal of Gastroenterology, 22(34), 7824.
   PubMed Web of Science ®Google Scholar
• Poveda, E., Wyles, D. L., Á, M., Pedreira, J. D., Á, C.-I., & Cachay, E. (2014). Update on hepatitis C virus resistance to direct-acting antiviral agents. Antiviral Research, 108, 181–191.
   PubMed Web of Science ®Google Scholar
• Price, D. A., Bassendine, M. F., Norris, S. M., Golding, C., Toms, G. L., Schmid, M. L., … Donaldson, P. T. (2006). Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection. Gut, 55(5), 715–718.
   PubMed Web of Science ®Google Scholar
• Radkowski, M., Wang, L.-F., Vargas, H. E., Rakela, J., & Laskus, T. (1998). Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation, 66(5), 664–666.
   PubMed Web of Science ®Google Scholar
• Radkowski, M., Wilkinson, J., Nowicki, M., Adair, D., Vargas, H., Ingui, C., … Laskus, T. (2002). Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. Journal of Virology, 76(2), 600–608.
   PubMed Web of Science ®Google Scholar
• Ragab, G., & Hussein, M. A. (2017). Vasculitic syndromes in hepatitis C virus: A review. Journal of Advanced Research, 8(2), 99–111.
   PubMed Web of Science ®Google Scholar
• Raison, C. L., Rye, D. B., Woolwine, B. J., Vogt, G. J., Bautista, B. M., Spivey, J. R., & Miller, A. H. (2010). Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biological Psychiatry, 68(10), 942–949.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals, M., Zignego, A., Ferri, C., Brito-Zerón, P., Retamozo, S., Casato, M., … Cacoub, P. (2017). International study group of extrahepatic manifestations related to HCV (ISG-EHCV). Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. Journal of Hepatology, 66(6), 1282–1299.
   PubMed Web of Science ®Google Scholar
• Ratai, E. M., Annamalai, L., Burdo, T., Joo, C. G., Bombardier, J. P., Fell, R., … González, R. G. (2011). Brain creatine elevation and NAA reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDS. Magnetic Resonance in Medicine, 66(3), 625–634.
   PubMed Web of Science ®Google Scholar
• Rehermann, B., & Nascimbeni, M. (2005). Immunology of hepatitis B virus and hepatitis C virus infection. Nature Reviews Immunology, 5(3), 215.
   PubMed Web of Science ®Google Scholar
• Reichenberg, A., Gorman, J. M., & Dieterich, D. T. (2005). Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. Aids, 19, S174–S8.
   PubMed Web of Science ®Google Scholar
• Rodrigue, J. R., Balistreri, W., Haber, B., Jonas, M. M., Mohan, P., Molleston, J. P., … González-Peralta, R. P. (2009). Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. Journal of Pediatric Gastroenterology and Nutrition, 48(3), 341.
   PubMed Web of Science ®Google Scholar
• Rodrigue, J. R., Balistreri, W., Haber, B., Jonas, M. M., Mohan, P., Molleston, J. P., … González-Peralta, R. P. (2011). Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/ emotional,and cognitive outcomes in children. Hepatology, 53(5), 1468–1475.
   PubMed Web of Science ®Google Scholar
• Rothenhäusler, H., Scherr, M., Putz-Bankuti, C., Kapper, A., Stepan, A., Baranyi, A., … Stauber, R. (2009). The relationship between emotional distress, cognitive performance and health-related quality of life in patients with hepatitis C prior to antiviral treatment. Fortschritte Der Neurologie-Psychiatrie, 77(8), 457–463.
   PubMed Web of Science ®Google Scholar
• Sockalingam, S., Blank, D., Al Jarad, A., Alosaimi, F., Hirschfield, G., & Abbey, S. E. (2011). A comparison of depression screening instruments in hepatitis C and the impact of depression on somatic symptoms. Psychosomatics, 52(5), 433–440.
   PubMed Web of Science ®Google Scholar
• Solinas, A., Piras, M. R., & Deplano, A. (2015). Cognitive dysfunction and hepatitis C virus infection. World Journal of Hepatology, 7(7), 922–925.
   PubMed Web of Science ®Google Scholar
• Spampinato, M. V., Castillo, M., Rojas, R., Palacios, E., Frascheri, L., & Descartes, F. (2005). Magnetic resonance imaging findings in substance abuse: alcohol and alcoholism and syndromes associated with alcohol abuse. Topics in Magnetic Resonance Imaging: TMRI, 16(3), 223–230.
   PubMedGoogle Scholar
• Struble, K., Chan‐Tack, K., Qi, K., Naeger, L. K., & Birnkrant, D. (2018). Benefit‐risk assessment for sofosbuvir/velpatasvir/voxilaprevir based on patient population and hepatitis C virus genotype: US Food and drug administration’s evaluation. Hepatology, 67(2), 482–491.
   PubMed Web of Science ®Google Scholar
• Sun, B., Abadjian, L., Rempel, H., Monto, A., & Pulliam, L. (2013). Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection. Journal of Acquired Immune Deficiency Syndromes (1999), 62(2), 190.
   PubMed Web of Science ®Google Scholar
• Sureka, B., Bansal, K., Patidar, Y., Rajesh, S., Mukund, A., & Arora, A. (2015). Neurologic manifestations of chronic liver disease and liver cirrhosis. Current Problems in Diagnostic Radiology, 44(5), 449–461.
   PubMed Web of Science ®Google Scholar
• Syed, G. H., Tang, H., Khan, M., Hassanein, T., Liu, J., & Siddiqui, A. (2014). Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. Journal of Virology, 88(5), 2519–2529.
   PubMed Web of Science ®Google Scholar
• Thames, A. D., Castellon, S. A., Singer, E. J., Nagarajan, R., Sarma, M. K., Smith, J., … Hinkin, C. H. (2015). Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C. Neurology-Neuroimmunology Neuroinflammation, 2(1), e59.
   PubMed Web of Science ®Google Scholar
• Thein, H., Maruff, P., Krahn, M., Kaldor, J., Koorey, D., Brew, B., & Dore, G. (2007). Cognitive function, mood and health‐related quality of life in hepatitis C virus (HCV)‐monoinfected and HIV/HCV‐coinfected individuals commencing HCV treatment. HIV Medicine, 8(3), 192–202.
   PubMed Web of Science ®Google Scholar
• Tournier, J.-D., Mori, S., & Leemans, A. (2011). Diffusion Tensor Imaging and Beyond. Magnetic Resonance in Medicine, 65(6), 1532–1556.
   PubMed Web of Science ®Google Scholar
• Valcour, V. G., Rubin, L. H., Obasi, M. U., Maki, P. M., Peters, M. G., Levin, S., … Tien, P. C. (2016). Liver fibrosis linked to cognitive performance in HIV and hepatitis C. Journal of Acquired Immune Deficiency Syndromes (1999), 72(3), 266.
   PubMed Web of Science ®Google Scholar
• Verma, A., Kumar, I., Verma, N., Aggarwal, P., & Ojha, R. (2016). Magnetic resonance spectroscopy — Revisiting the biochemical and molecular milieu of brain tumors. BBA Clinical, 5, 170–178.
   PubMed Web of Science ®Google Scholar
• Vitali, C., Wellington, C. L., & Calabresi, L. (2014). HDL and cholesterol handling in the brain. Cardiovascular Research, 103(3), 405–413.
   PubMed Web of Science ®Google Scholar
• Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schüler, A., Ennen, J. C., … Böker, K. W. (2004). Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 41(5), 845–851.
   PubMed Web of Science ®Google Scholar
• Weller, R., Hueging, K., Brown, R. J. P., Todt, D., Joecks, S., Vondran, F. W. R., … Schmitz, R. A. (2017). Hepatitis C virus strain-dependent usage of apolipoprotein E modulates assembly efficiency and specific infectivity of secreted virions. Journal of Virology, 91(18), pii: e00422-17.
   Web of Science ®Google Scholar
• Wijarnpreecha, K., Cheungpasitporn, W., Pungpapong, S., & Nakkala, K. R. (2018). Treatment of the extrahepatic manifestations of chronic hepatitis C infection. Clinical Liver Disease, 11(5), 115–118.
   Google Scholar
• Wilkinson, J., Radkowski, M., & Laskus, T. (2009). Hepatitis C virus neuroinvasion: identification of infected cells. Journal of Virology, 83(3), 1312–1319.
   PubMed Web of Science ®Google Scholar
• Wozniak, M., Lugo Iparraguirre, L., Dirks, M., Deb‐Chatterji, M., Pflugrad, H., Goldbecker, A., … Weissenborn, K. (2016). Apolipoprotein E‐ε4 deficiency and cognitive function in hepatitis C virus‐infected patients. Journal of Viral Hepatitis, 23(1), 39–46.
   PubMed Web of Science ®Google Scholar
• Yang, Z.-T., Chen, Q.-F., Lin, H., & Chen, H.-J. (2018). Disrupted brain intrinsic networks and executive dysfunction in cirrhotic patients without overt hepatic encephalopathy. Frontiers in Neurology, 9, 14.
   PubMed Web of Science ®Google Scholar
• Zayed, H. S., Amin, A., Alsirafy, S., Elsayed, N. D., Elfadl, S. A., Nasreldin, M., … Nawito, Z. (2018). Psychiatric and functional neuroimaging abnormalities in chronic hepatitis C virus patients: Is vasculitis a contributing factor? Arab Journal of Gastroenterology, 19, 71–75.
   PubMed Web of Science ®Google Scholar
• Zignego, A. L., & Craxì, A. (2008). Extrahepatic manifestations of hepatitis C virus infection. Clinics in Liver Disease, 12(3), 611–636.
   PubMed Web of Science ®Google Scholar